Published in Lancet on December 13, 2003
Functional Genomic Influences on Disease Progression and Outcome in Sepsis (GAinS) | NCT00131196
Community Acquired Pneumonia: Outcome, Quality of Life and Immune Status (CAPolista) | NCT02141009
Epidemiology of human metapneumovirus. Clin Microbiol Rev (2006) 1.88
Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PLoS One (2013) 1.84
RespiFinder: a new multiparameter test to differentially identify fifteen respiratory viruses. J Clin Microbiol (2008) 1.49
Augmented lung inflammation protects against influenza A pneumonia. PLoS One (2009) 1.47
Stimulation of lung innate immunity protects against lethal pneumococcal pneumonia in mice. Am J Respir Crit Care Med (2008) 1.44
Lung epithelium as a sentinel and effector system in pneumonia--molecular mechanisms of pathogen recognition and signal transduction. Respir Res (2006) 1.39
Ventilator-associated Pneumonia caused by commensal oropharyngeal Flora; [corrected] a retrospective Analysis of a prospectively collected Database. BMC Pulm Med (2015) 1.39
Stimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi. Am J Respir Cell Mol Biol (2009) 1.36
Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial. Crit Care (2011) 1.30
Pulmonary disposition of tedizolid following administration of once-daily oral 200-milligram tedizolid phosphate in healthy adult volunteers. Antimicrob Agents Chemother (2012) 1.12
Multiplex quantitative PCR for detection of lower respiratory tract infection and meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis. BMC Microbiol (2010) 1.12
Epidemiology of respiratory viral infections in two long-term refugee camps in Kenya, 2007-2010. BMC Infect Dis (2012) 1.09
Etiologic diagnosis of adult bacterial pneumonia by culture and PCR applied to respiratory tract samples. J Clin Microbiol (2006) 1.08
Extracellular matrix formation enhances the ability of Streptococcus pneumoniae to cause invasive disease. PLoS One (2011) 1.08
PfbA, a novel plasmin- and fibronectin-binding protein of Streptococcus pneumoniae, contributes to fibronectin-dependent adhesion and antiphagocytosis. J Biol Chem (2008) 1.08
Ten years of antibiotic consumption in ambulatory care: trends in prescribing practice and antibiotic resistance in Austria. BMC Infect Dis (2009) 1.03
Plasminogen- and fibronectin-binding protein B is involved in the adherence of Streptococcus pneumoniae to human epithelial cells. J Biol Chem (2010) 1.03
Comparison of two urinary antigen tests for establishment of pneumococcal etiology of adult community-acquired pneumonia. J Clin Microbiol (2004) 1.00
Streptococcus pneumoniae endopeptidase O (PepO) is a multifunctional plasminogen- and fibronectin-binding protein, facilitating evasion of innate immunity and invasion of host cells. J Biol Chem (2013) 0.98
The role of vaccination in preventing pneumococcal disease in adults. Clin Microbiol Infect (2014) 0.98
Prediction of the pathogens that are the cause of pneumonia by the battlefield hypothesis. PLoS One (2011) 0.96
Pneumococcal capsular polysaccharide vaccine-mediated protection against serotype 3 Streptococcus pneumoniae in immunodeficient mice. Infect Immun (2007) 0.96
Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway. BMC Infect Dis (2015) 0.95
Comparative transcriptional profiling of the lung reveals shared and distinct features of Streptococcus pneumoniae and influenza A virus infection. Immunology (2006) 0.95
Recent changes in the management of community acquired pneumonia in adults. BMJ (2008) 0.92
Quantitative analysis of lung ultrasonography for the detection of community-acquired pneumonia: a pilot study. Biomed Res Int (2015) 0.91
Longitudinal analysis of pneumococcal antibodies during community-acquired pneumonia reveals a much higher involvement of Streptococcus pneumoniae than estimated by conventional methods alone. Clin Vaccine Immunol (2011) 0.91
Atypical pathogens as etiologic agents in hospitalized patients with community-acquired pneumonia in Korea: a prospective multi-center study. J Korean Med Sci (2006) 0.91
The crystal structure of alanine racemase from Streptococcus pneumoniae, a target for structure-based drug design. BMC Microbiol (2011) 0.91
Differential activation of inflammatory pathways in A549 type II pneumocytes by Streptococcus pneumoniae strains with different adherence properties. BMC Infect Dis (2006) 0.91
Inhaled therapeutics for prevention and treatment of pneumonia. Expert Opin Drug Saf (2009) 0.89
Protective activity of Streptococcus pneumoniae Spr1875 protein fragments identified using a phage displayed genomic library. PLoS One (2012) 0.89
Aetiology of community-acquired pneumonia among adults in an H1N1 pandemic year: the role of respiratory viruses. Eur J Clin Microbiol Infect Dis (2012) 0.88
The Fcgamma receptor IIA-R/R131 genotype is associated with severe sepsis in community-acquired pneumonia. Clin Vaccine Immunol (2009) 0.87
Purification and preliminary crystallization of alanine racemase from Streptococcus pneumoniae. BMC Microbiol (2007) 0.86
Allergic lung inflammation alters neither susceptibility to Streptococcus pneumoniae infection nor inducibility of innate resistance in mice. Respir Res (2009) 0.86
Measurement of complement receptor 1 on neutrophils in bacterial and viral pneumonia. BMC Infect Dis (2006) 0.85
Viral etiology of community-acquired pneumonia among adolescents and adults with mild or moderate severity and its relation to age and severity. BMC Infect Dis (2015) 0.85
Evaluation of a rapid immunochromatographic ODK0501 assay for detecting Streptococcus pneumoniae antigen in sputum samples from patients with lower respiratory tract infection. Clin Vaccine Immunol (2009) 0.85
Assessment of analysis of urinary pneumococcal antigen by immunochromatography for etiologic diagnosis of community-acquired pneumonia in adults. Clin Vaccine Immunol (2006) 0.85
Dysbiosis of upper respiratory tract microbiota in elderly pneumonia patients. ISME J (2015) 0.85
Systematic review regarding metabolic profiling for improved pathophysiological understanding of disease and outcome prediction in respiratory infections. Respir Res (2015) 0.85
Evaluation of yield of currently available diagnostics by sample type to optimize detection of respiratory pathogens in patients with a community-acquired pneumonia. Influenza Other Respir Viruses (2013) 0.84
Disease burden of pneumonia in Korean adults aged over 50 years stratified by age and underlying diseases. Korean J Intern Med (2014) 0.84
Respiratory viral infections and effects of meteorological parameters and air pollution in adults with respiratory symptoms admitted to the emergency room. Influenza Other Respir Viruses (2013) 0.84
Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatment of bacterial community-acquired pneumonia in adults. Antimicrob Agents Chemother (2004) 0.82
Colobronchial fistula presenting with persistent pneumonia in a patient with Crohn's disease: a case report. Cases J (2009) 0.82
Detection and serotyping of pneumococci in community acquired pneumonia patients without culture using blood and urine samples. BMC Infect Dis (2015) 0.82
Role of non-conventional T lymphocytes in respiratory infections: the case of the pneumococcus. PLoS Pathog (2014) 0.81
Use of sensitive, broad-spectrum molecular assays and human airway epithelium cultures for detection of respiratory pathogens. PLoS One (2012) 0.81
Monitoring the long-term molecular epidemiology of the pneumococcus and detection of potential 'vaccine escape' strains. PLoS One (2011) 0.81
Detection of pneumonia associated pathogens using a prototype multiplexed pneumonia test in hospitalized patients with severe pneumonia. PLoS One (2014) 0.81
R-roscovitine reduces lung inflammation induced by lipoteichoic acid and Streptococcus pneumoniae. Mol Med (2012) 0.81
Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infect Dis (2016) 0.80
Role of beta-lactam agents in the treatment of community-acquired pneumonia. Eur J Clin Microbiol Infect Dis (2005) 0.80
Studying the burden of community-acquired pneumonia in adults aged ≥50 years in primary health care: an observational study in rural Crete, Greece. NPJ Prim Care Respir Med (2014) 0.78
Adjuvant corticosteroids for patients hospitalized with community-acquired pneumonia: is it time? J Thorac Dis (2016) 0.78
Aboriginal and non-Aboriginal children in Western Australia carry different serotypes of pneumococci with different antimicrobial susceptibility profiles. Pneumonia (Nathan) (2016) 0.77
Pulmonary Immunostimulation with MALP-2 in Influenza Virus-Infected Mice Increases Survival after Pneumococcal Superinfection. Infect Immun (2015) 0.77
Pneumonia in the neutropenic cancer patient. Curr Opin Pulm Med (2015) 0.77
Dexamethasone treatment has no effect on the formation of pneumococcal antibodies during community-acquired pneumonia. Clin Vaccine Immunol (2012) 0.77
Respiratory virus is a real pathogen in immunocompetent community-acquired pneumonia: comparing to influenza like illness and volunteer controls. BMC Pulm Med (2014) 0.77
Antimicrobial susceptibility of Streptococcus pneumoniae in adult patients with pneumococcal pneumonia in an urban hospital in Mozambique. BMC Res Notes (2014) 0.76
Effect of ethanol on fluoroquinolone efficacy in a rat model of pneumococcal pneumonia. Antimicrob Agents Chemother (2006) 0.76
Influenza and other respiratory viruses involved in severe acute respiratory disease in northern Italy during the pandemic and postpandemic period (2009-2011). Biomed Res Int (2014) 0.76
Inducible epithelial resistance protects mice against leukemia-associated pneumonia. Blood (2016) 0.76
Predictors of viral pneumonia in patients with community-acquired pneumonia. PLoS One (2014) 0.75
Incidence and etiology of hospitalized acute respiratory infections in the Egyptian Delta. Influenza Other Respir Viruses (2016) 0.75
Time-dependent association of glucocorticoids with adverse outcome in community-acquired pneumonia: a 6-year prospective cohort study. Crit Care (2017) 0.75
Streptococcus pneumoniae Colonization Disrupts the Microbial Community within the Upper Respiratory Tract of Aging Mice. Infect Immun (2016) 0.75
The Most Common Detected Bacteria in Sputum of Patients with Community Acquired Pneumonia (CAP) Treated In Hospital. Med Arch (2016) 0.75
Clinical Application of High-Resolution Computed Tomographic Imaging Features of Community-Acquired Pneumonia. Med Sci Monit (2016) 0.75
Incidence of Hospitalized Pneumococcal Pneumonia among Adults in Guatemala, 2008-2012. PLoS One (2015) 0.75
Viral respiratory infections in a nursing home: a six-month prospective study. BMC Infect Dis (2016) 0.75
Exogenous Activation of Invariant Natural Killer T Cells by α-Galactosylceramide Reduces Pneumococcal Outgrowth and Dissemination Postinfluenza. MBio (2016) 0.75
Activation of lung toll-like receptors does not exacerbate sickness responses to lipopolysaccharide in mice. Brain Behav Immun (2014) 0.75
Validation of an administrative claims-based diagnostic code for pneumonia in a US-based commercially insured COPD population. Int J Chron Obstruct Pulmon Dis (2015) 0.75
Prospective etiological investigation of community-acquired pulmonary infections in hospitalized people living with HIV. Medicine (Baltimore) (2017) 0.75
Treatment of community-acquired pneumonia, with special emphasis on gemifloxacin. Ther Clin Risk Manag (2007) 0.75
Using Standardized Interpretation of Chest Radiographs to Identify Adults with Bacterial Pneumonia--Guatemala, 2007-2012. PLoS One (2015) 0.75
Etiology of Influenza-Like Illnesses from Sentinel Network Practitioners in Réunion Island, 2011-2012. PLoS One (2016) 0.75
Diagnostic usefulness of ribosomal protein l7/l12 for pneumococcal pneumonia in a mouse model. J Clin Microbiol (2012) 0.75
Antibiotic susceptibility in Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus pyogenes in Pakistan: a review of results from the Survey of Antibiotic Resistance (SOAR) 2002-15. J Antimicrob Chemother (2016) 0.75
Bacteraemic and non-bacteraemic/urinary antigen-positive pneumococcal community-acquired pneumonia compared. Eur J Clin Microbiol Infect Dis (2014) 0.75
Lysophosphatidylcholine as a prognostic marker in community-acquired pneumonia requiring hospitalization: a pilot study. Eur J Clin Microbiol Infect Dis (2014) 0.75
Discrepant serological assays for Pneumococcus in renal transplant recipients - a prospective study. Transpl Int (2017) 0.75